| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/07/1995 | US5395922 Yeast processing system |
| 03/07/1995 | US5395759 Vaccines, medical diagnosis |
| 03/02/1995 | WO1995006065A1 Cytokines that bind the cell surface receptor hek |
| 03/02/1995 | WO1995006056A1 Bridged polycationic polymer-oligonucleotide conjugates and methods for preparing same |
| 03/02/1995 | WO1995006055A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 03/02/1995 | WO1995005847A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | WO1995005835A1 Gene therapy for solid tumors, papillomas and warts |
| 03/02/1995 | WO1995001437A3 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 03/02/1995 | DE4425481A1 Melanoma-inhibiting protein |
| 03/02/1995 | CA2169851A1 Cytokines that bind the cell surface receptor hek |
| 03/02/1995 | CA2169849A1 Accessory factor function for interferon gamma and its receptor |
| 03/02/1995 | CA2169748A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 03/02/1995 | CA2105364A1 Stem-loop oligonucleotides containing parallel and antiparallel binding domains |
| 03/01/1995 | EP0640688A1 Ribozymes |
| 03/01/1995 | EP0640619A1 Erythropoietin analogs with additional glycosylation sites |
| 03/01/1995 | EP0640148A1 Microwave modification of biological macromolecules. |
| 03/01/1995 | EP0640143A1 Senescent cell derived inhibitors of dna synthesis |
| 03/01/1995 | EP0640133A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/01/1995 | EP0640098A1 Canine coronavirus s gene and uses therefor |
| 03/01/1995 | EP0640097A1 Compositions and methods for vaccination against coronaviruses |
| 03/01/1995 | EP0640096A1 Universal coronavirus vaccine |
| 03/01/1995 | EP0640093A1 Human crabp-i and crabp-ii |
| 02/28/1995 | US5393878 Pyrimidine nucleosides having cyclopentafuran skeleton |
| 02/28/1995 | US5393877 Forming first oligonucleotide on first cleavable link attached to solid support, attaching a cleavable linker moiety, forming second oligonucleotide on the cleavable linker moiety, cleaving to give plurality of oligonucleotides |
| 02/28/1995 | US5393670 DNA, vectors and transformed hosts encoding Trichoderma reesei endoglucanase I |
| 02/28/1995 | US5393615 Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof |
| 02/28/1995 | CA1334580C Diagnosis of chronic myelogenous leukemia |
| 02/23/1995 | WO1995005470A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor |
| 02/23/1995 | WO1995005465A1 Erythropoietin analogs |
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005462A2 Nucleic acid probes to ureaplasma |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/23/1995 | WO1995005391A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
| 02/23/1995 | DE4407538C1 Binding reagent for cell surface protein and effector cell |
| 02/23/1995 | DE4328332A1 Method of synthesising and selecting sequences of covalently bonded building blocks |
| 02/23/1995 | CA2145750A1 Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides |
| 02/22/1995 | EP0639649A2 Nucleic acid probes to ureaplasma |
| 02/22/1995 | EP0639582A2 Polynucleotide assay reagent and method |
| 02/22/1995 | EP0639230A1 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum |
| 02/22/1995 | EP0639200A1 Methods and reagents for cleaving and deprotecting oligonucleotides |
| 02/21/1995 | US5391785 Partially protected alcohols, used to make phosphoramidites for modifying oligonucleotides |
| 02/21/1995 | US5391723 Oligonucleotide conjugates |
| 02/16/1995 | WO1995004834A1 Method of manufacturing a matrix for the detection of mismatches |
| 02/16/1995 | WO1995004829A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | WO1995004821A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 02/16/1995 | WO1995004816A1 Compositions and methods for producing sialyltransferases |
| 02/16/1995 | WO1995004754A1 Antimicrobial proteins |
| 02/16/1995 | WO1995004751A1 Selectin binding glycopeptides |
| 02/16/1995 | WO1995004748A1 Oligomers for modulating viral processes |
| 02/16/1995 | WO1995004747A1 Infra-red dye-labelled nucleotides and their use in nucleic acid detection |
| 02/16/1995 | WO1995004745A1 Method of nucleic acid sequence selection |
| 02/16/1995 | WO1995004744A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | WO1994028176A3 Bc200 rna, probes therefor and use thereof |
| 02/16/1995 | WO1994023028A3 Modified oligonucleotides having improved anti-influenza activity |
| 02/16/1995 | CA2170234A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168566A1 Method and reagent for inhibiting human immunodeficiency virus replication |
| 02/16/1995 | CA2168454A1 Selectin binding glycopeptides |
| 02/16/1995 | CA2168448A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | CA2167489A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | CA2166309A1 Antimicrobial proteins |
| 02/15/1995 | EP0638168A1 Capillary electrophoresis molecular weight separation of biomolecules using a polymer-containing solution |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638089A1 Synthesis of diverse and useful collections of oligonucleotides |
| 02/15/1995 | EP0638088A1 Hybrid human/porcine factor viii |
| 02/15/1995 | EP0638087A1 Modified nucleotides |
| 02/15/1995 | EP0637965A1 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/14/1995 | US5389543 Cloned genes encoding the D1 dopamine receptor |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389515 Isolated nucleotide sequences for identifying Neisseria gonorrhoeae |
| 02/14/1995 | CA1334385C Carrier for dna-hybridization |
| 02/09/1995 | WO1995004162A2 Dna sequencing enzymes |
| 02/09/1995 | WO1995004160A1 Tag reagent and assay method |
| 02/09/1995 | WO1995004151A2 Vaccine compositions containing recombinant tetc-fusion proteins |
| 02/09/1995 | WO1995004150A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 02/09/1995 | WO1995004142A2 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004068A1 Oligomers for modulating human immunodeficiency virus |
| 02/09/1995 | WO1995004066A1 Building blocks with carbamate internucleoside linkages and novel oligonucleotides derived therefrom |
| 02/09/1995 | WO1995004065A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/09/1995 | WO1995003833A1 Oligomers for modulating protein kinase c |
| 02/09/1995 | WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2168471A1 Dna sequencing enzymes |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | CA2167679A1 Building blocks with carbamate internucleoside linkages and novel oligonucleotides derived therefrom |
| 02/09/1995 | CA2167671A1 Processes and intermediates for phosphorous-containing covalent linkages |
| 02/08/1995 | EP0637344A1 Electrochemical treatment of surfaces |
| 02/08/1995 | EP0637342A1 Process for typing of hcv isolates |
| 02/08/1995 | EP0637341A1 A predictive assay for suicidal behavior |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637314A1 N-acylated 2'-deoxycytidines useful in oligonucleotide synthesis |
| 02/08/1995 | EP0601117A4 SYNTHETIC tRNAs. |